LAM
BSX icon

LECAP Asset Management’s Boston Scientific BSX Stock Holding History

LECAP Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
+44,117
New +$2.4M 0.81% 24
2026
Q1 		– Sell
-18,408
Closed -$1.76M – 286
2025
Q4 		$1.76M Buy
+18,408
New +$1.8M 0.7% 36
2025
Q3 		– Sell
-27,070
Closed -$2.91M – 284
2025
Q2 		$2.91M Buy
+27,070
New +$2.74M 1.03% 4

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LECAP Asset Management's BSX Position: Q2 2026 in Review

LECAP Asset Management opened a new position in Boston Scientific (BSX) in Q2 2026: 44,117 shares worth $1.88M. The stake represents 0.81% of the portfolio and ranks #24 among its holdings. This is a return to the name: LECAP Asset Management previously reported a position in BSX as recently as Q4 2025.

LECAP Asset Management first reported a position in BSX in Q2 2025 and has held it in 3 quarters since. The position peaked at $2.91M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • LECAP Asset Management held 44,117 shares of Boston Scientific worth $1.88M as of Q2 2026.
  • Boston Scientific was a new LECAP Asset Management position in Q2 2026.
  • Boston Scientific made up 0.81% of LECAP Asset Management's portfolio in Q2 2026, its #24 holding.
  • LECAP Asset Management first reported a position in Boston Scientific in Q2 2025 and has held it in 3 quarters since.
  • LECAP Asset Management's Boston Scientific position peaked at $2.91M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.